IP Library › Granted Patent US 11,666,603
Granted Patent B2
US 11,666,603 · App. 16/471,191 · Granted Jun 6, 2023

Methods and compositions for purification or isolation of microvesicles and exosomes

Inventors: Chacko Joseph (Blackburn, AU); Jim Palmer (Blackburn, AU); Ian Dixon (Blackburn, AU); Gregor Lichtfuss (Blackburn, AU)
Assignee: EXOPHARM LIMITED
A61K35/28B01D15/08B01D15/20B01D15/362B01D15/3823B01D15/3828B01J20/262B01J20/3274B01J39/26C12N5/00B01D2015/3838C07K14/435
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,666,603
App. No.
16/471,191
Granted
Jun 6, 2023
Kind
B2
Abstract

The invention relates to the isolation or extraction of exosomes.

Claims (40)

1. A method for obtaining a composition or an isolate of exosomes or microvesicles comprising:

providing a liquid that includes exosomes or microvesicles;

providing a substrate having a surface, the surface having an array of exosome-binding ligands, wherein the array is formed from one or more polymers having the exosome-binding ligands, wherein at least 60% of ligands of the array are spaced between 5 and 10 angstroms apart from another ligand of the array;

wherein each ligand is in the form of an anionic group at pH 4-8; and

wherein the array of exosome-binding ligands enables exosomes or microvesicles to bind to the substrate;

contacting the liquid with the substrate in conditions enabling the binding of exosomes or microvesicles to the exosome-binding ligands;

separating the substrate from the liquid;

eluting exosomes or microvesicles from the exosome-binding ligands to release the exosomes or microvesicles from the substrate after the substrate is separated from the liquid;

separating the released exosomes or microvesicles from the substrate;

thereby obtaining a composition or isolate of exosomes or microvesicles.

2. The method of claim 1 , wherein the one or more polymers include a monomer species having at least one exosome-binding ligand.

3. The method of claim 2 , wherein at least 25% of the monomers of the one or more polymers includes an exosome-binding ligand.

4. The method of claim 2 , wherein all monomers of the one or more polymers have an exosome-binding ligand.

5. The method of claim 1 , wherein at least 60% of ligands of the array are spaced between 6 and 10 angstroms apart from another ligand of the array.

6. The method of claim 1 , wherein two or more monomeric species include an exosome-binding ligand.

7. The method of claim 1 , wherein part of the substrate surface includes the array.

8. The method of claim 1 , wherein the polymer is selected from the group comprising: polysaccharide; polyethylene terephthalate; peptide; nucleic acid; organic molecules; and combinations thereof.

9. The method of claim 8 , wherein the polymer is a polysaccharide or peptide.

10. The method of claim 9 , wherein the polymer is a peptide selected from the group comprising: polyaspartic acid, polyserine, polythreonine, polyasparagine, and combinations thereof.

11. The method of claim 9 , wherein the polysaccharide is selected from the group comprising: pyranoses and amino sugars, wherein the pyranose comprises monomers selected from: dextrose, glucose, galactose, glucosamine, galactosamine, mannose, ribose, arabinose, xylose, lyxose, and combinations thereof.

12. The method of claim 9 , wherein the peptide is selected from the group comprising:

polyaspartic acid, polyserine, polythreonine, polyasparagine, polycysteic acic, polyselenocysteic acid, D-configured amino acids of the same, and combinations thereof.

13. The method of claim 8 , wherein the polymer is an organic molecule selected from the group comprising: polyethers, (PEGS), sulfated polyvinyl alcohols, polyphenols, polyphenylboronic acids, polyaromatics, polyheteroaromatics, and combinations thereof.

14. The method of claim 1 , wherein the polymer is a synthetic polymer.

15. The method of claim 1 , wherein the one or more polymers form the substrate.

16. The method of claim 1 , wherein the one or more polymers are coupled to the substrate.

17. The method of claim 1 , wherein the one or more polymers are soluble in the liquid.

18. An apparatus including a substrate according to claim 1 and enabling the execution of a method according to claim 1 .

19. The method of claim 1 , wherein the array is planar and includes a region of exosome-binding ligands having a density of 2 to 4 ligands per nm 2 .

20. The method of claim 19 , wherein the array includes a region of exosome-binding ligands having a density of 3 to 4 ligands per nm 2 .

21. The method of claim 1 , wherein the polymer has a molecular weight of 10 to 900 kDa.

22. The method of claim 1 , wherein the polymer contains 100 to 400 monomers.

23. The method of claim 1 , wherein the anionic group is selected from the group comprising: sulfates, selenates, phosphates, phosphonates, phosphinates, sulfated alcohols, carboxylate groups, acylsulfonamides and combinations thereof.

24. The method of claim 1 , wherein the anionic group is selected from the group comprising: CO 2 H, CH 2 OSO 3 H, B(OH) 2 , CH 2 OP(O)(OH) 2 , ionized forms thereof, and combinations thereof.

25. The method of claim 1 , wherein the polymer is selected from the group comprising:

cellulose sulfate, cellulose phosphate, chitosan, chondroitin sulfate, dextran sulfate, poly(methyl vinyl ether-maleic anhydride), boronic acid polymer, polyaspartic acid, substituted poly-β-asparagine, polyserine, polyserine sulfate and combinations thereof.

26. The method of claim 1 , wherein the polymer is selected from the group comprising:

cellulose sulfate, dextran sulfate, polyacrylamide sulfoisobutyl, and combinations thereof.

27. The method of claim 1 , wherein the polymer is selected from the group comprising:

cellulose sulfate, cellufine sulfate, dextran sulfate and combinations thereof.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 049519 FRAME: 0541. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 29, 2021
From: JOSEPH, CHACKO; PALMER, JIM; DIXON, IAN; LICHTFUSS, GREGOR
To: EXOPHARM LIMITED
Reel/Frame 057972/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2019
From: JOSEPH, CHACKO; PALMER, JIM; DIXON, IAN; LICHTFUSS, GREGOR
To: EXOPHARM LTD
Reel/Frame 049519/0541 →
Priority Claims (1)
AU 2016905369 · Dec 23, 2016 · national
Continuity (1)
Related Publication 20200023012A1 · Jan 23, 2020